調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Bioabsorbable Stent/Bioresorbable Scaffold Market by Material (Polymer/Metal), Absorption Rate (Slow, Fast), Application (Coronary Artery Disease/CAD, Peripheral/PAD) & End User (Hospital, Cardiovascular Center) - Global Forecasts to 2022

生体吸収性ステント/生体吸収性スキャフォールドの世界市場予測（～2022年）

◆タイトル：Bioabsorbable Stent/Bioresorbable Scaffold Market by Material (Polymer/Metal), Absorption Rate (Slow, Fast), Application (Coronary Artery Disease/CAD, Peripheral/PAD) & End User (Hospital, Cardiovascular Center) - Global Forecasts to 2022
◆商品コード：MAM-MD4383
◆調査・発行会社：MarketsandMarkets
◆発行日：2017年8月21日
◆ページ数：140
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）

Single User（1名利用）	USD5,650 ⇒換算￥621,500	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥731,500	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥896,500	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、生体吸収性ステント/生体吸収性スキャフォールドの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、材料別分析、吸収速度別分析、用途別分析、需要先別分析、生体吸収性ステント/生体吸収性スキャフォールドの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global bioresorbable stents market is expected to reach USD 417.2 Million by 2022 from USD 223.6 Million in 2016, at a CAGR of 11.5% during the forecast period 2017-2022. Market growth of bioresorbable stents is attributed to the growing aging population susceptible to coronary and peripheral artery diseases, rising PCI procedures, increasing focus of companies on clinical trials of bioresorbable stents, increasing adoption of these stents by physicians and patients, and patients’ preference for minimally invasive therapies. However, factors such as the increasing product withdrawals due to severe complications of these stents may hamper market growth.
This report segments the global bioresorbable stents market into material, absorption rate, applications, end users, and region. On the basis of materials, the global bioresorbable stents market is segmented into bioresorbable polymer-based stents and bioresorbable metallic stents. The bioresorbable polymer-based segment is expected to dominate the market in 2017. The preference for bioresorbable polymer-based stents is rising in the market as companies are increasingly focusing on developing polymeric stents and approvals for polymer-based stents across various regions are driving the market.

Based on end users, the market is segmented into hospitals and cardiac centers. The hospitals segment is expected to dominate the market and grow at the highest CAGR of during the forecast period. The high growth in this segment is attributed to increasing need of surgeries, growing risk of CAD and PAD, and improving reimbursement scenario for the hospitals.

By absorption rate, the global bioresorbable stents market is segmented into slow-absorption stents and fast-absorption stents. In 2017, the slow-absorption stents segment is expected to account for the largest share of the market. The large share of this segment can be attributed to the advantages it offers such as the longer duration of drug release within the artery provided by these stents and the reduced need for stent re-implantation.

In 2017, Europe is expected to dominate the global bioresorbable stents market. Factors such as increasing regulatory approvals for stents which will facilitate their commercialization and rising research activities for development of bioresorbable stents in the region are expected to drive the growth of this regional segment.

The global bioresorbable stents market is a niche market with the presence of several emerging players. Prominent players in the bioresorbable stents market include Abbott Laboratories (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), and Kyoto Medical Planning Co., Ltd. (Japan).

【レポートの目次】

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders

2 Research Methodology (Page No. – 17)
2.1 Research Approach
2.2 Secondary Data
2.3 Primary Data
2.4 Key Industry Insights
2.5 Market Size Estimation
2.6 Market Breakdown and Data Triangulation
2.7 Assumptions for the Study

3 Executive Summary (Page No. – 25)

4 Premium Insights (Page No. – 29)
4.1 Bioresorbable Stents Market Overview
4.2 Bioresorbable Stents Market, By End User
4.3 Bioresorbable Stents Market, By Application
4.4 Bioresorbable Stents Market, By Material
4.5 Bioresorbable Stents Market: Geographic Snapshot

5 Market Overview (Page No. – 32)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rapidly Growing Geriatric Population and Increased Risk of CAD and PAD in the Elderly
5.2.1.2 Strong Product Pipeline
5.2.2 Restraints
5.2.2.1 Presence of Substitutes
5.2.3 Opportunities
5.2.3.1 Emerging Markets to Offer High-Growth Opportunities for Market PartiCIPAnts
5.2.4 Challenges
5.2.4.1 Product Withdrawals and Failures
5.2.4.2 High Risk of Complications

6 Regulatory Scenario (Page No. – 38)
6.1 Introduction
6.2 FDA and Ce Approvals
6.3 PMA Approvals and Government Certificates

7 Bioresorbable Stents Market, By Material (Page No. – 40)
7.1 Introduction
7.2 Bioresorbable Polymer-Based Stents
7.3 Bioresorbable Metallic Stents

8 Bioresorbable Stents Market, By Absorption Rate (Page No. – 46)
8.1 Introduction
8.2 Slow-Absorption Stents
8.3 Fast-Absorption Stents

9 Bioresorbable Stents Market, By Application (Page No. – 51)
9.1 Introduction
9.2 Coronary Artery Disease
9.3 Peripheral Artery Disease

10 Bioresorbable Stents Market, By End User (Page No. – 57)
10.1 Introduction
10.2 Hospitals
10.3 Cardiac Centers

11 Bioresorbable Stents Market, By Region (Page No. – 63)
11.1 Introduction
11.2 Europe
11.2.1 Germany
11.2.2 France
11.2.3 U.K.
11.2.4 Rest of Europe (RoE)
11.3 Asia
11.4 North America
11.4.1 U.S.
11.4.2 Canada
11.5 Rest of the World

12 Competitive Landscape (Page No. – 89)
12.1 Introduction
12.2 Market Ranking Analysis
12.3 Competitive Leadership Mapping
12.3.1 Visionary Leaders
12.3.2 Innovators
12.3.3 Emerging Companies
12.3.4 Dynamic Differentiators
12.4 Competitive Benchmarking
12.4.1 Strength of the Product Portfolio
12.4.2 Business Strategy Excellence

Abbott, REVA Medical, Inc., Elixir Medical Corporation, KYOTO MEDICAL PLANNING Co., Ltd., BIOTRONIK, Amaranth Medical, Inc., Arterial Remodeling Technologies, Meril Life Sciences Pvt. Ltd., Arterius Limited, LEPU MEDICAL TECHNOLOGY CO., LTD., Boston Scientific Corporation, HangZhou HuaAn Biotechnology Co.,Ltd, S3V Vascular Technologies, QualiMed, SMT, TEPHA INC, Manli Cardiology Ltd., ORBUSNEICH, 480 Biomedical, Zorion Medical Inc, Lifetech Scientific (Shenzhen) Co., Ltd

13 Company Profiles (Page No. – 94)
(Business Overview, Strength of Service Portfolio, Business Strategy Excellence, and Key Relationships)*
13.1 Abbott
13.2 REVA Medical, Inc.
13.3 Elixir Medical Corporation
13.4 KYOTO MEDICAL PLANNING Co., Ltd.
13.5 BIOTRONIK
13.6 Amaranth Medical, Inc.
13.7 Arterial Remodeling Technologies
13.8 Meril Life Sciences Pvt. Ltd.
13.9 Arterius Limited
13.10 LEPU MEDICAL TECHNOLOGY CO., LTD.
13.11 Boston Scientific Corporation
13.12 480 Biomedical
13.13 S3V Vascular Technologies Private Limited
13.14 Qualimed (Part of Q3 Medical Group)
13.15 ORBUSNEICH

*Details on Business Overview, Strength of Service Portfolio, Business Strategy Excellence, and Key Relationships Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 128)
14.1 Insights From Industry Experts
14.2 Discussion Guide
14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports
14.7 Author Details

List of Tables (73 Tables)

Table 1 Pipeline Products in the Bioresorbable Stents Market
Table 2 List of the Approved Products
Table 3 Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 4 Bioresorbable Polymer-Based Stents Market, By Region, 2015–2022 (USD Million)
Table 5 North America: Bioresorbable Polymer-Based Stents Market, By Country, 2015–2022 (USD Million)
Table 6 Europe: Bioresorbable Polymer-Based Stents Market, By Country, 2015–2022 (USD Million)
Table 7 Bioresorbable Metallic Stents Market, By Region, 2017–2022 (USD Million)
Table 8 Europe: Bioresorbable Metallic Stents Market, By Country, 2017–2022 (USD Million)
Table 9 Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 10 Slow-Absorption Stents Market, By Region, 2015–2022 (USD Million)
Table 11 Europe: Slow-Absorption Stents Market, By Country, 2015–2022 (USD Million)
Table 12 North America: Slow-Absorption Stents Market, By Country, 2015–2022 (USD Million)
Table 13 Fast-Absorption Stents Market, By Region, 2015–2022 (USD Million)
Table 14 Europe: Fast-Absorption Stents Market, By Country, 2015–2022 (USD Million)
Table 15 North America: Fast-Absorption Stents Market, By Country, 2015–2022 (USD Million)
Table 16 Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 17 Bioresorbable Stents Market for Coronary Artery Disease, By Region, 2015–2022 (USD Million)
Table 18 North America: Bioresorbable Stents Market for Coronary Artery Disease, By Country, 2015–2022 (USD Million)
Table 19 Europe: Bioresorbable Stents Market for Coronary Artery Disease, By Country, 2015–2022 (USD Million)
Table 20 Bioresorbable Stents Market for Peripheral Artery Disease, By Region, 2015–2022 (USD Million)
Table 21 Europe: Bioresorbable Stents Market for Peripheral Artery Disease, By Country, 2015–2022 (USD Million)
Table 22 Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 23 Bioresorbable Stents Market for Hospitals, By Region, 2015–2022 (USD Million)
Table 24 North America: Bioresorbable Stents Market for Hospitals, By Country, 2015–2022 (USD Million)
Table 25 Europe: Bioresorbable Stents Market for Hospitals, By Country, 2015–2022 (USD Million)
Table 26 Bioresorbable Stents Market for Cardiac Centers, By Region, 2015–2022 (USD Million)
Table 27 North America: Bioresorbable Stents Market for Cardiac Centers, By Country, 2015–2022 (USD Million)
Table 28 Europe: Bioresorbable Stents Market for Cardiac Centers, By Country, 2015–2022 (USD Million)
Table 29 Bioresorbable Stents Market, By Region, 2015–2022 (USD Million)
Table 30 Bioresorbable Stents Market, By Region, 2015–2022 (Units)
Table 31 Europe: Bioresorbable Stents Market, By Country, 2015–2022 (USD Million)
Table 32 Europe: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 33 Europe: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 34 Europe: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 35 Europe: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 36 Germany: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 37 Germany: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 38 Germany: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 39 Germany: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 40 France: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 41 France: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 42 France: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 43 France: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 44 U.K.: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 45 U.K.: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 46 U.K.: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 47 U.K.: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 48 RoE: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 49 RoE: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 50 RoE: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 51 RoE: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 52 Asia: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 53 Asia: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 54 Asia: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 55 Asia: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 56 North America: Bioresorbable Stents Market, By Country, 2015–2022 (USD Million)
Table 57 North America: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 58 North America: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 59 North America: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 60 North America: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 61 U.S.: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 62 U.S.: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 63 U.S.: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 64 U.S.: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 65 Canada: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 66 Canada: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 67 Canada: Bioresorbable Stents Market, By Type, 2015–2022 (USD Million)
Table 68 Canada: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 69 RoW: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 70 RoW: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 71 RoW: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 72 RoW: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 73 Bioresorbable Stents Market Ranking Analysis, By Key Player, 2016

List of Figures (33 Figures)

Figure 1 Bioresorbable Stents Market
Figure 2 Research Design
Figure 3 Key Data From Secondary Sources
Figure 4 Key Data From Primary Sources
Figure 5 Market Size Estimation: Bottom -Up Approach
Figure 6 Market Size Estimation: Top-Down Approach
Figure 7 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 8 Data Triangulation Methodology
Figure 9 Bioresorbable Polymer-Based Stents to Dominate the Market During the Forecast Period
Figure 10 Bioresorbable Stents Market, By Absorption Rate (2017 vs 2022)
Figure 11 Coronary Artery Disease to Register Highest Growth in the Bioresorbable Stents Application Market (2017-2022)
Figure 12 Hospitals to Offer Significant Growth Opportunities During the Forecast Period
Figure 13 North America is Expected to Witness the Highest Growth During the Forecast Period
Figure 14 Rising Geriatric Population and Increased Risk of CAD and PAD to Drive Market Growth During the Forecast Period
Figure 15 Hospitals Accounted for the Largest Market Share in 2017
Figure 16 Coronary Artery Diseases to Witness Highest Growth During the Forecast Period
Figure 17 Bioresorbable Polymer-Based Stents to Witness the Highest Growth During the Forecast Period
Figure 18 North America to Witness the Highest Growth in the Bioresorbable Stents Market During the Forecast Period
Figure 19 Bioresorbable Stents Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Prevalence of CAD, By Age and Gender (2009–2012)
Figure 21 Bioabsorbable Stents Market, By Material (2017 vs 2022)
Figure 22 Slow Absorption Stents to Dominate the Bioresorbable Stents Market in 2017
Figure 23 Coronary Artery Disease to Dominate the Bioresorbable Stents Application Market in 2017
Figure 24 Hospitals to Register Highest Growth in the Bioresorbable Stents End-User Market in 2017
Figure 25 Europe to Dominate the Bioresorbable Stents Market in 2017
Figure 26 Europe: Bioresorbable Stents Market Snapshot
Figure 27 Asia: Bioresorbable Stents Market Snapshot
Figure 28 North America: Bioresorbable Stents Market Snapshot
Figure 29 RoW Bioresorbable Stents Market Snapshot (2017)
Figure 30 Competitive Leadership Mapping
Figure 31 Abbott: Company Snapshot (2016)
Figure 32 REVA Medical, Inc.: Company Snapshot (2016)
Figure 33 Boston Scientific Corporation: Company Snapshot (2016)

【レポートのキーワード】

生体吸収性ステント、生体吸収性スキャフォールド、生体吸収性材料、生体吸収性ポリマー、生体吸収性金属、疾患、治療、医療用途

★調査レポート[生体吸収性ステント/生体吸収性スキャフォールドの世界市場予測（～2022年）] ( Bioabsorbable Stent/Bioresorbable Scaffold Market by Material (Polymer/Metal), Absorption Rate (Slow, Fast), Application (Coronary Artery Disease/CAD, Peripheral/PAD) & End User (Hospital, Cardiovascular Center) - Global Forecasts to 2022 / MAM-MD4383) 販売に関する免責事項

[生体吸収性ステント/生体吸収性スキャフォールドの世界市場予測（～2022年）] ( Bioabsorbable Stent/Bioresorbable Scaffold Market by Material (Polymer/Metal), Absorption Rate (Slow, Fast), Application (Coronary Artery Disease/CAD, Peripheral/PAD) & End User (Hospital, Cardiovascular Center) - Global Forecasts to 2022 / MAM-MD4383) についてEメールでお問い合わせ

◆H&Iグローバルリサーチ株式会社のお客様（例）◆